These findings are consistent with observations in multiple lung adenocarcinoma models bearing STK11 and KEAP1 mutations, where elevated expression of SCD1, due to inactivated LKB1-AMPK signaling, resulted in ferroptosis resistance (Wohlhieter et al., 2020). This evidence concerns the gene STK11 and lung adenocarcinoma.